• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT TRIMA ACCEL; TRIMA ACCEL PLATELET SAMPLER, PLASMA, RBC SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT TRIMA ACCEL; TRIMA ACCEL PLATELET SAMPLER, PLASMA, RBC SET Back to Search Results
Catalog Number 80440
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Infiltration into Tissue (1931)
Event Date 01/01/2009
Event Type  Injury  
Manufacturer Narrative
Investigation: the customer indicated that they were not able to search for the donation record due to the age of the incident.Therefore, a dhr search could not be conducted for this specific incident.All lots must meet acceptance criteria for release.The customer also indicated that the incident occurred over 9 years ago and the disposable set was not available for return, and the procedural details were unavailable.Root cause: a definitive root cause could not be determined.Possible causes include but are not limited to:- phlebotomist inadvertently sticking the needle through the distal side of the vein.- abrading the needle entry site.- abrading the vein wall due to needle movement during the procedure.- an excessive high intravenous pressure by having a higher flow rate than could be accommodated by the cannulated vein.Per terumo bct's internal medical review, insufficient information is provided to determine whether the trima system caused or contributed to the donor¿s infiltration event.
 
Event Description
During a discussion between a terumo bct representative and a (b)(6) employee, it was brought up that an infiltration had occurred back in 2009 with a female donor.There was no mention of any medical intervention that took place, but the customer was sure that the facility completed an in-house injury report and followed up with the donor.Donor information and outcome are not available as the organization had recently changed their software and was unable to search for the donor's donation record.Due to the time that has passed, the trima disposable set is not available for evaluation because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information.
 
Event Description
Per the customer, no medical intervention occurred as a result of this incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIMA ACCEL
Type of Device
TRIMA ACCEL PLATELET SAMPLER, PLASMA, RBC SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
steve kern
10810 w. collins ave.
lakewood, CO 80215
3032392246
MDR Report Key7876895
MDR Text Key120282641
Report Number1722028-2018-00253
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583804401
UDI-Public05020583804401
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK080058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number80440
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 08/21/2018
Initial Date FDA Received09/14/2018
Supplement Dates Manufacturer Received09/26/2018
Supplement Dates FDA Received10/09/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-